{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:35:01Z","timestamp":1776710101861,"version":"3.51.2"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ctim.2017.10.014","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T07:47:40Z","timestamp":1510213660000},"page":"140-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Efficacy and safety of a combination of red yeast rice and olive extract in hypercholesterolemic patients with and without statin-associated myalgia"],"prefix":"10.1016","volume":"35","author":[{"given":"Christian","family":"Tshongo Muhindo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie A.","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel F.","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvan","family":"Dierckxsens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel P.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2017.10.014_bib0005","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins","volume":"366","author":"CTT-Cholesterol treatment trialists\u2019 (CTT) Collaborators","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ctim.2017.10.014_bib0010","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctim.2017.10.014_bib0015","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/bmj.38793.468449.AE","article-title":"Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials","volume":"332","author":"Costa","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ctim.2017.10.014_bib0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"CTT-Cholesterol treatment trialists\u2019 (CTT) Collaborators","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ctim.2017.10.014_bib0025","doi-asserted-by":"crossref","first-page":"B2376","DOI":"10.1136\/bmj.b2376","article-title":"The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials","volume":"338","author":"Brugts","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ctim.2017.10.014_bib0030","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","volume":"32","author":"European Association for Cardiovascular Prevention","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ctim.2017.10.014_bib0035","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ctim.2017.10.014_bib0040","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Califf RM; IMPROVE-IT investigators: ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctim.2017.10.014_bib0045","series-title":"Diabetes in cardiovascular disease: a companion to Braunwald\u2019s heart disease","first-page":"181","article-title":"Effect of lipid management on coronary heart disease risk in patients with diabetes","author":"Hermans","year":"2015"},{"key":"10.1016\/j.ctim.2017.10.014_bib0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1043-4526(07)53004-4","article-title":"Monascus rice products","volume":"53","author":"Wang","year":"2007","journal-title":"Adv Food Nutr Res"},{"issue":"2","key":"10.1016\/j.ctim.2017.10.014_bib0055","first-page":"22","article-title":"Role of nutraceuticals in hypolipidemic therapy","volume":"11","author":"Barbagallo","year":"2015","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ctim.2017.10.014_bib0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12906-015-0576-9","article-title":"Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome? A double blind, placebo controlled randomized trial","volume":"15","author":"Verhoeven","year":"2015","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.ctim.2017.10.014_bib0065","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.nutres.2013.05.015","article-title":"Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects","volume":"33","author":"Cicero","year":"2013","journal-title":"Nutr Res"},{"key":"10.1016\/j.ctim.2017.10.014_bib0070","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.nut.2016.04.007","article-title":"Lipid-modifying effects of nutraceuticals: an evidence-based approach","volume":"32","author":"Sahebkar","year":"2016","journal-title":"Nutrition"},{"key":"10.1016\/j.ctim.2017.10.014_bib0075","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.amjcard.2010.01.337","article-title":"Red yeast rice and statin-intolerant patients","volume":"105","author":"Cicero","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ctim.2017.10.014_bib0080","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1080\/14656566.2016.1197202","article-title":"Expert opinion: the therapeutic challenges faced by statin intolerance","volume":"17","author":"Patel","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ctim.2017.10.014_bib0085","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2017.07.752","article-title":"Optimizing Cholesterol treatment in patients with muscle complaints","volume":"70","author":"Rosenson","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ctim.2017.10.014_bib0090","doi-asserted-by":"crossref","first-page":"965","DOI":"10.5114\/aoms.2017.69326","article-title":"Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel","volume":"13","author":"Cicero","year":"2017","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.ctim.2017.10.014_bib0095","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1055\/s-0035-1546017","article-title":"Andreadou Effects of the olive tree leaf constituents on myocardial oxidative damage and atherosclerosis","volume":"81","author":"Efentakis","year":"2015","journal-title":"Planta Med"},{"key":"10.1016\/j.ctim.2017.10.014_bib0100","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1517\/14740338.2015.1039980","article-title":"Statin intolerance \u2013 an attempt at a unified definition: position paper from an International Lipid Expert Panel","volume":"14","author":"Banach","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ctim.2017.10.014_bib0105","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Ginsberg HN; european atherosclerosis society consensus panel statin-associated muscle symptoms: impact on statin therapy-European atherosclerosis society consensus panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ctim.2017.10.014_bib0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1475-2840-9-88","article-title":"Rousseau MF. log(TG)\/HDL-C is related to both residual cardiometabolic risk and \u03b2-cell function loss in type 2 diabetes males","volume":"9","author":"Hermans","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ctim.2017.10.014_bib0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1475-2840-12-39","article-title":"Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DM","volume":"12","author":"Hermans","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ctim.2017.10.014_bib0120","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0021-9150(98)00034-3","article-title":"Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol\/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL","volume":"138","author":"Hattori","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ctim.2017.10.014_bib0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s005920200037","article-title":"LDLcholesterol\/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes","volume":"39","author":"Wagner","year":"2002","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.ctim.2017.10.014_bib0130","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1177\/2047487313489875","article-title":"Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: an analysis from the VOYAGER database","volume":"20","author":"Palmer","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ctim.2017.10.014_bib0135","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.atherosclerosis.2014.10.105","article-title":"Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysi","volume":"237","author":"Ambegaonkar","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ctim.2017.10.014_bib0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjcard.2009.08.651","article-title":"Meta-analysis of comparative efficacy of increasing dose of atorvastatin versus rosuvastatin versus simvastatin on lowering levels of atherogenic lipids (from VOYAGER)","volume":"105","author":"Nicholls","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ctim.2017.10.014_bib0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.dsx.2006.11.003","article-title":"The non-HDL-C\/HDL-C ratio provides cardiovascular risk stratification similar to the ApoB\/ApoA1 ratio in diabetics: comparison with reference lipid markers","volume":"1","author":"Hermans","year":"2007","journal-title":"Diab Metab Syndr"},{"key":"10.1016\/j.ctim.2017.10.014_bib0150","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4093\/dmj.2015.39.5.353","article-title":"Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia","volume":"39","author":"Parhofer","year":"2015","journal-title":"Diabetes Metab J"},{"issue":"12","key":"10.1016\/j.ctim.2017.10.014_bib0155","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12967-014-0219-9","article-title":"Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: focus on protection against cardiovascular and metabolic diseases","volume":"3","author":"Bulotta","year":"2014","journal-title":"J Transl Med"},{"key":"10.1016\/j.ctim.2017.10.014_bib0160","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/jf405820v","article-title":"Hydroxytyrosol and its potential therapeutic effects","volume":"62","author":"Hu","year":"2014","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.ctim.2017.10.014_bib0165","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamacardio.2016.0096","article-title":"Association of lipoproteins, insulin resistance, and rosuvastatin with incident type 2 diabetes mellitus: secondary analysis of a randomized clinical trial","volume":"1","author":"Dugani","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ctim.2017.10.014_bib0170","doi-asserted-by":"crossref","first-page":"e98611","DOI":"10.1371\/journal.pone.0098611","article-title":"A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ctim.2017.10.014_bib0175","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00394-014-0761-5","article-title":"Rapid down-regulation of hepatic lipid metabolism by phenolic fraction from extra virgin olive oil","volume":"54","author":"Priore","year":"2015","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.ctim.2017.10.014_bib0180","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00394-016-1188-y","article-title":"Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial","volume":"56","author":"Lockyer","year":"2016","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.ctim.2017.10.014_bib0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.acvd.2016.05.002","article-title":"Impact of a public media event on the use of statins in the French population","volume":"110","author":"Bezin","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.ctim.2017.10.014_bib0190","doi-asserted-by":"crossref","first-page":"e843","DOI":"10.3390\/ijms17060843","article-title":"Nutraceutical properties of olive oil polyphenols: an itinerary from cultured cells through animal models to humans","volume":"17","author":"Rigacci","year":"2016","journal-title":"Int J Mol Sci"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229917305769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229917305769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:08:00Z","timestamp":1760807280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229917305769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":38,"alternative-id":["S0965229917305769"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2017.10.014","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of a combination of red yeast rice and olive extract in hypercholesterolemic patients with and without statin-associated myalgia","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2017.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}